Pu Ni

572 total citations
23 papers, 416 citations indexed

About

Pu Ni is a scholar working on Nephrology, Genetics and Molecular Biology. According to data from OpenAlex, Pu Ni has authored 23 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nephrology, 12 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Pu Ni's work include Parathyroid Disorders and Treatments (16 papers), Genetic Syndromes and Imprinting (9 papers) and Fibroblast Growth Factor Research (8 papers). Pu Ni is often cited by papers focused on Parathyroid Disorders and Treatments (16 papers), Genetic Syndromes and Imprinting (9 papers) and Fibroblast Growth Factor Research (8 papers). Pu Ni collaborates with scholars based in United States, China and Australia. Pu Ni's co-authors include Kenneth E. White, Megan L. Noonan, Rafiou Agoro, Erica L. Clinkenbeard, Matthew R. Allen, Julia M. Hum, Elizabeth A. Swallow, Taryn A. Cass, Teresita Bellido and Samantha Tippen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Journal of Applied Physiology.

In The Last Decade

Pu Ni

20 papers receiving 412 citations

Peers

Pu Ni

NEPHR

MB

GENET

HEMAT

ND

Brian Czaya United States

Amie K. Gray United States

Erica L. Clinkenbeard United States

Christopher Yanucil United States

Joseph Boulanger United States

A Gupta United Kingdom

Fujun Lin China

Taryn A. Cass United States

Eva S. Liu United States

Nariaki Asada Japan

Brian Czaya United States

Pu Ni

430 ×1.9

NEPHR

221 ×1.2

MB

182 ×1.6

GENET

43 ×0.6

HEMAT

117 ×1.7

ND

Citations per year, relative to Pu Ni Pu Ni (= 1×) peers Brian Czaya

Countries citing papers authored by Pu Ni

Since Specialization

Citations

This map shows the geographic impact of Pu Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pu Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pu Ni more than expected).

Fields of papers citing papers by Pu Ni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pu Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pu Ni. The network helps show where Pu Ni may publish in the future.

Co-authorship network of co-authors of Pu Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Pu Ni. A scholar is included among the top collaborators of Pu Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pu Ni. Pu Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Ni, Pu, et al.. (2025). Diagnostic and prognostic significance of Crohn's disease‐like pathology in surgically diverted recta of patients with ulcerative colitis. Histopathology. 87(1). 81–89.

2.

Agoro, Rafiou, Jered Myslinski, Danielle Janosevic, et al.. (2025). Dynamic single cell transcriptomics defines kidney FGF23/KL bioactivity and novel segment-specific inflammatory targets. Kidney International. 107(4). 687–699. 1 indexed citations

3.

Cai, Zhaoxian, Xiaotian Wu, Tianyi Wang, et al.. (2025). SLC39A8-mediated zinc dyshomeostasis potentiates kidney disease. Proceedings of the National Academy of Sciences. 122(38). e2426352122–e2426352122. 2 indexed citations

4.

Liang, Jingjia, Wentao Shao, Pu Ni, et al.. (2024). siRNA/CS‐PLGA Nanoparticle System Targeting Knockdown Intestinal SOAT2 Reduced Intestinal Lipid Uptake and Alleviated Obesity (Adv. Sci. 40/2024). Advanced Science. 11(40).

5.

Liang, Jingjia, Wentao Shao, Pu Ni, et al.. (2024). siRNA/CS‐PLGA Nanoparticle System Targeting Knockdown Intestinal SOAT2 Reduced Intestinal Lipid Uptake and Alleviated Obesity. Advanced Science. 11(40). e2403442–e2403442. 7 indexed citations

6.

Jain, Dhanpat, Pu Ni, Barton Kenney, et al.. (2024). von Meyenburg complexes are more frequently associated with cholangiocarcinoma. Journal of Clinical Pathology. 78(5). 300–306. 3 indexed citations

7.

Noonan, Megan L., Pu Ni, Rafiou Agoro, et al.. (2023). Osteocyte Egln1/Phd2 links oxygen sensing and biomineralization via FGF23. Bone Research. 11(1). 7–7. 14 indexed citations

8.

Ni, Pu, et al.. (2023). A Rare Case of Breast Metastatic Gastrointestinal Stromal Tumor. Cureus. 15(1). e34164–e34164.

9.

Jiang, Li, Jiaming Wang, Kai Wang, et al.. (2021). RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. Blood. 138(8). 689–705. 99 indexed citations

10.

Ni, Pu, et al.. (2021). Identification of a second Klotho interaction site in the C terminus of FGF23. Cell Reports. 34(4). 108665–108665. 19 indexed citations

11.

Tippen, Samantha, Megan L. Noonan, Pu Ni, et al.. (2021). Age and sex effects on FGF23-mediated response to mild phosphate challenge. Bone. 146. 115885–115885. 18 indexed citations

12.

Noonan, Megan L., Pu Ni, Rafiou Agoro, et al.. (2020). The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse Model. Journal of Bone and Mineral Research. 36(6). 1117–1130. 18 indexed citations

13.

Agoro, Rafiou, Pu Ni, Megan L. Noonan, & Kenneth E. White. (2020). Osteocytic FGF23 and Its Kidney Function. PMC. 2 indexed citations

14.

Noonan, Megan L., Erica L. Clinkenbeard, Pu Ni, et al.. (2020). Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD). PMC. 1 indexed citations

15.

Agoro, Rafiou, Pu Ni, Megan L. Noonan, & Kenneth E. White. (2020). Osteocytic FGF23 and Its Kidney Function. Frontiers in Endocrinology. 11. 592–592. 42 indexed citations

16.

Ni, Pu, Erica L. Clinkenbeard, Megan L. Noonan, et al.. (2020). Targeting fibroblast growth factor 23-responsive pathways uncovers controlling genes in kidney mineral metabolism. Kidney International. 99(3). 598–608. 7 indexed citations

17.

Clinkenbeard, Erica L., Megan L. Noonan, Joseph C. Thomas, et al.. (2019). Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD. JCI Insight. 4(4). 45 indexed citations

18.

Hum, Julia M., Linda M. O’Bryan, Erica L. Clinkenbeard, et al.. (2019). Sustained Klotho delivery reduces serum phosphate in a model of diabetic nephropathy. Journal of Applied Physiology. 126(4). 854–862. 4 indexed citations

19.

Corbin, Braden, Olena Andrukhova, Julia M. Hum, et al.. (2017). Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels. Endocrinology. 158(5). 1130–1139. 33 indexed citations

20.

Clinkenbeard, Erica L., Taryn A. Cass, Pu Ni, et al.. (2016). Conditional Deletion of Murine Fgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia. PMC. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact